Protective Efficacy of Inhaled BCG Vaccination Against Ultra-Low Dose Aerosol
BCG
T-cell memory
aerosol vaccination
immunogenicity
macaque
non-human primate
tuberculosis
vaccine
Journal
Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003
Informations de publication
Date de publication:
25 Apr 2020
25 Apr 2020
Historique:
received:
07
04
2020
revised:
21
04
2020
accepted:
22
04
2020
entrez:
30
4
2020
pubmed:
30
4
2020
medline:
30
4
2020
Statut:
epublish
Résumé
Ten million cases of tuberculosis (TB) were reported in 2018 with a further 1.5 million deaths attributed to the disease. Improved vaccination strategies are urgently required to tackle the ongoing global TB epidemic. In the absence of a validated correlate of protection, highly characterised pre-clinical models are required to assess the protective efficacy of new vaccination strategies. In this study, we demonstrate the application of a rhesus macaque ultra-low dose (ULD) aerosol
Identifiants
pubmed: 32344890
pii: pharmaceutics12050394
doi: 10.3390/pharmaceutics12050394
pmc: PMC7284565
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
JAMA. 1994 Mar 2;271(9):698-702
pubmed: 8309034
J Immunol. 2016 Aug 15;197(4):1100-1110
pubmed: 27412415
Infect Immun. 2015 Mar;83(3):852-62
pubmed: 25547788
PLoS One. 2017 Mar 8;12(3):e0171906
pubmed: 28273087
J Comp Pathol. 2013 Nov;149(4):475-85
pubmed: 23880551
Biomed Res Int. 2017;2017:5089752
pubmed: 28512637
Infect Immun. 2003 Oct;71(10):5831-44
pubmed: 14500505
Lancet. 2006 Apr 8;367(9517):1173-80
pubmed: 16616560
J Clin Invest. 2006 Jun;116(6):1514-24
pubmed: 16691294
Infect Immun. 2004 Feb;72(2):1065-71
pubmed: 14742554
Mol Med. 2012 May 09;18:647-58
pubmed: 22396020
Nat Med. 2011 Sep 18;17(10):1290-7
pubmed: 21926977
Int J Tuberc Lung Dis. 2001 Jul;5(7):664-72
pubmed: 11467373
Tuberculosis (Edinb). 2009 Nov;89(6):405-16
pubmed: 19879805
J Aerosol Med Pulm Drug Deliv. 2014 Oct;27(5):341-8
pubmed: 25105472
Cytometry A. 2011 Feb;79(2):167-74
pubmed: 21265010
J Comp Pathol. 2015 Feb-Apr;152(2-3):217-26
pubmed: 25481611
J Appl Microbiol. 2011 Aug;111(2):350-9
pubmed: 21651681
Proc Jpn Acad Ser B Phys Biol Sci. 2011;87(8):463-85
pubmed: 21986312
Proc Natl Acad Sci U S A. 2008 Mar 25;105(12):4656-60
pubmed: 18344320
Clin Vaccine Immunol. 2015 Sep;22(9):992-1003
pubmed: 26108288
J Pharmacol Toxicol Methods. 2004 Jan-Feb;49(1):39-55
pubmed: 14670693
Tuberculosis (Edinb). 2017 May;104:46-57
pubmed: 28454649
Tuberculosis (Edinb). 2016 Jan;96:1-12
pubmed: 26786648
J Immunol. 2002 Jan 1;168(1):29-43
pubmed: 11751943
Int J Tuberc Lung Dis. 1998 Mar;2(3):200-7
pubmed: 9526191
Nat Rev Immunol. 2008 Apr;8(4):247-58
pubmed: 18323851
J Immunol. 2013 Jun 15;190(12):6320-8
pubmed: 23690470
Tuberculosis (Edinb). 2016 Dec;101:174-190
pubmed: 27865390
Nature. 2020 Jan;577(7788):95-102
pubmed: 31894150
J Hyg (Lond). 1969 Sep;67(3):437-48
pubmed: 5258223
Expert Rev Mol Diagn. 2012 Mar;12(2):175-87
pubmed: 22369377
N Engl J Med. 2018 Jul 12;379(2):138-149
pubmed: 29996082
Int J Immunopharmacol. 1994 May-Jun;16(5-6):435-44
pubmed: 7927990
Infect Immun. 2018 Jan 22;86(2):
pubmed: 29203540
Adv Drug Deliv Rev. 2014 Aug;75:3-17
pubmed: 24732364
Am Rev Respir Dis. 1973 Mar;107(3):351-8
pubmed: 4632221
Expert Rev Vaccines. 2019 Dec;18(12):1271-1284
pubmed: 31876199
Clin Vaccine Immunol. 2010 Aug;17(8):1170-82
pubmed: 20534795
Curr Drug Deliv. 2008 Apr;5(2):114-9
pubmed: 18393813
Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11497-502
pubmed: 11562492